Company News in the Life Science Industry

»

Reset 

Oncobiologics Announces Conversion of Majority of Series A Convertible Preferred Stock

Read more ››
By: Nasdaq / GlobenewsWire - 20 Jun 2018

Two Publications Recognize NovuHealth as a Top Workplace in Minnesota

Read more ››
By: Nasdaq / GlobenewsWire - 20 Jun 2018

The nuclear medicine market is projected to grow at a CAGR of 5.9%

LONDON, June 20, 2018 /PRNewswire/ -- The nuclear medicine market is projected to grow at a CAGR of 5.9%
The nuclear medicine market is projected to reach USD 5.26 billion by 2023 from USD 3.95 billion in 2018. Factors such as the growing incidence and prevalence of cancer and cardiac... Read more ››

By: PR Newswire Association LLC. - 20 Jun 2018

Global Hearing Protection Devices Markets 2016-2024: Recent Industry Activity, Product Innovations, Key Growth Drivers, Competition & Trends

DUBLIN, June 20, 2018 /PRNewswire/ --

Read more ››
By: PR Newswire Association LLC. - 20 Jun 2018

PATH and SD BIOSENSOR announce partnership to advance diagnostic test critical for malaria treatment and elimination

Agreement supports development and availability of an affordable, high-quality enzyme deficiency test

Read more ››
By: PR Newswire Association LLC. - 20 Jun 2018

Kindred Biosciences Announces the Termination of Its At-The-Market Equity Offering Program

SAN FRANCISCO, June 20, 2018 /PRNewswire/ -- Kindred Biosciences, Inc. (NASDAQ: KIN), a commercial-stage biopharmaceutical company focused on saving and improving the lives of pets, today announced the termination of its "at-the-market" equity offering program (the "ATM Facility") with B. Riley... Read more ››

By: PR Newswire Association LLC. - 20 Jun 2018
Related companies:  Kindred Biosciences, Inc.

Rigel Announces Poster Presentations at FOCIS Annual Meeting

SOUTH SAN FRANCISCO, Calif., June 20, 2018 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that Dr. Anne-Marie Duliege, Chief Medical Officer, will be presenting two posters on fostamatinib at the Federation of Clinical Immunology Societies (FOCIS) Annual Meeting in... Read more ››

By: PR Newswire Association LLC. - 20 Jun 2018
Related companies:  Rigel Pharmaceuticals, Inc.

Memorial Hermann Southeast Hospital Selected for National Baby-Friendly® Designation Program

HOUSTON, June 20, 2018 /PRNewswire-USNewswire/ -- Memorial Hermann Southeast Hospital has received prestigious international recognition as a Baby-Friendly® Designated birth facility by Read more ››

By: PR Newswire Association LLC. - 20 Jun 2018
Related companies:  Memorial Hermann Healthcare System

Great Point Partners, LLC Remains Opposed To The BioCryst Pharmaceutical Proposed Merger With Idera Pharmaceuticals, Inc.

GREENWICH, Conn., June 20, 2018 /PRNewswire/ -- Great Point Partners, LLC ("GPP") today submitted a letter to the Board of Directors of BioCryst Pharmaceuticals, Inc. ("BCRX") expressing its continued opposition to BCRX's proposed merger with Idera Pharmaceuticals, Inc. The full text of the letter... Read more ››

By: PR Newswire Association LLC. - 20 Jun 2018
Related companies:  BioCryst Pharmaceuticals, Inc. | Idera Pharmaceuticals Inc.

Zimmer Biomet Holdings Announces Audio Webcast and Conference Call of Second Quarter 2018 Results

WARSAW, Ind., June 20, 2018 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) today announced its second quarter sales and earnings conference call will be broadcast over the Internet on Friday, July 27, 2018, at 8:30 a.m. Eastern Time. A news release detailing the quarterly results... Read more ››

By: PR Newswire Association LLC. - 20 Jun 2018
Related companies:  Zimmer Biomet

Global Laparoscopic Devices Markets 2016-2018 & 2024 - Innovative 3D Camera Systems and Laparoscopes Swamp the Market

DUBLIN, June 20, 2018 /PRNewswire/ --

Read more ››
By: PR Newswire Association LLC. - 20 Jun 2018

Tenon Medical, Inc. Receives FDA Clearance For Sacroiliac Joint Fusion System

SAN RAMON, Calif., June 20, 2018 /PRNewswire/ -- Tenon Medical, Inc., a manufacturer of minimally invasive instruments and implants for sacroiliac joint fusion surgery, today announced that it has received 510(k) clearance from the United States Food and Drug Administration (FDA) for the Catamaran(TM)... Read more ››

By: PR Newswire Association LLC. - 20 Jun 2018

 Is pot bad for your heart? Truth is… we don’t know yet

Read more ››
By: Nasdaq / GlobenewsWire - 20 Jun 2018
Related companies:  University of Ottawa Heart Institute

Bio-on inaugurates in Italy the first special bioplastics production plant. 100% natural and biodegradable

Read more ››
By: Nasdaq / GlobenewsWire - 20 Jun 2018

Novacap to expand its pharmaceutical offering in the U.S. with the acquisition of PCI Synthesis

Read more ››
By: Nasdaq / GlobenewsWire - 20 Jun 2018
Related companies:  PCI Synthesis | PCI SYNTHESIS

ContraVir Pharmaceuticals Regains Compliance with Nasdaq Listing Requirements

Read more ››
By: Nasdaq / GlobenewsWire - 20 Jun 2018
Related companies:  ContraVir Pharmaceuticals, Inc.

Frost & Sullivan 2018 Award for Innovation in Artificial Intelligence for Aging Research and Drug Development

TAIPEI, Taiwan, June 20, 2018 /PRNewswire/ -- Rockville, MD, June 20, 2018, Insilico Medicine has been awarded the prestigious 2018 North American Technology Innovation Award from Frost & Sullivan for its pioneering work in Artificial Intelligence for Aging Research and Drug Development.... Read more ››

By: PR Newswire Association LLC. - 20 Jun 2018
Related companies:  InSilico Medicine, Inc.

New RayStation 8A Release Adds Support for TomoDirect Treatment Delivery

STOCKHOLM, June 20, 2018 /PRNewswire/ --

Read more ››
By: PR Newswire Association LLC. - 20 Jun 2018
Related companies:  RaySearch Laboratories AB

AIVITA Biomedical Announces U.S. Food and Drug Administration Clearance of IND for Phase II Glioblastoma Multiforme Trial

IRVINE, Calif., June 20, 2018 /PRNewswire/ -- AIVITA Biomedical, a biotech company specializing in innovative stem cell applications, announced today the U.S. Food and Drug Administration (FDA) has cleared its Investigational New Drug (IND) application for a Phase II clinical trial investigating... Read more ››

By: PR Newswire Association LLC. - 20 Jun 2018
Related companies:  AIVITA BIOMEDICAL

FDA Grants QIDP Designation to Acurx's Lead Antibiotic Product Candidate, ACX-362E for Clostridium Difficile Infection

WHITE PLAINS, NY., June 20, 2018 /PRNewswire/ -- Acurx Pharmaceuticals, LLC ("Acurx" or the "Company"), a privately held clinical stage biopharmaceutical company focused on developing new antibiotics for difficult to treat infections, today announced that the U.S. Food and Drug Administration... Read more ››

By: PR Newswire Association LLC. - 20 Jun 2018
«  1  2  3  4  5  6  7  8  9 10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »

Explore our database of over 50,000 companies